Skip to content

A retrospective clinical study on the treatment of infantile spasms with corticotropic hormone for injection (ACTH)

A retrospective clinical study on the treatment of infantile spasms with corticotropic hormone for injection (ACTH)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105285
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile spasms

Interventions

Observation group:NA

Sponsors

Daxing Campus of Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: (1)Children who were hospitalized in the Pediatric Neurology Ward of Peking University First Hospital from January 1, 2015 to December 31, 2024. (2) Children diagnosed with infantile spasms (meeting the 2022 ILAE diagnostic criteria for infantile epileptic spasms syndrome). (3) The age of onset is no more than 24 months. (4) The patient received intravenous infusion of ACTH treatment for the first time, and there were still convulsive seizures and highly irregular EEG manifestations at the beginning of the treatment. (5) Have EEG examination reports within 2 months before treatment and 3 months after treatment.

Exclusion criteria

Exclusion criteria: (1) Those who received intravenous ACTH treatment for the first time and had received intramuscular ACTH treatment. (2) Those who received ACTH treatment for the first time and were treated with amhexenoic acid (VGB) at the same time (except for those who received amhexenoic acid (VGB) treatment after the initial ACTH treatment). (3) Those who have used VGB within one month before using ACTH. (4) Those who have previously received treatment with ACTH and other corticosteroids.

Design outcomes

Primary

MeasureTime frame
The total effective rate of electro-therapeutic clinical efficacy evaluation;The total number and proportion of cases where severe dysrhythmia on EEG disappeared;The total number and proportion of people whose spasm attacks completely disappeared;

Countries

China

Contacts

Public ContactJiangYuwu

Peking University First Hospital

17639843553@163.com+86 176 3984 3553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026